Hi Colorado. then i would suggest the company to not even
Hi Colorado. then i would suggest the company to not even bother doing any PRs for a while until they are done diluting for a while because it is a waste of money that serves no purpose when any buys by anyone will be sold at .0001 though the diluting mms.
So basically these tons of .0001s people are holding will just be sold off for a 100% profit at .0002 when the company gets their shit straight.
Been an absolute waste of investment and time for me for the past year and a half only to come to this. Basically everything this company did in the past 2 years was a black hole that accomplished not a single thing but drop the pps to no bid! I wished i had listened to the many smart ones that dumped this a long long time ago. and now i sit with no certificates, down about $60,000 and a bunch of very upset family members, friends, and acquaintances. This is by far the dumbest investment i have ever made hands down by a long shot!
It took me a year and a half to finally accept this.
Drone Services USA Inc (DSUS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Russel Metals Inc. Reports Third Quarter Results for 2025 Russel Metals Inc. (TSX:RUS) has recently shared its financial performance for the three-month period ending September 30, 2025. The results reflect a positive trajectory in revenue and strategic initiatives to enhance its market position. Key Financial Metrics Overview In this quarter, Russel Metals has...
Continue Reading
KBC Group's Capital Position Remains Strong KBC Group has reported a robust standing in its capital levels, significantly exceeding the minimum capital requirements mandated by the European Central Bank (ECB). As part of the Supervisory Review and Evaluation Process (SREP) scheduled for the upcoming year, KBC received formal notification regarding its capital metrics....
Continue Reading
Synlogic Provides Third Quarter 2024 Financial Results Synlogic, Inc. (NASDAQ: SYBX), a prominent biopharmaceutical firm dedicated to developing innovative therapeutics for serious diseases, has recently outlined its financial performance for the third quarter of 2024. The organization is actively working on advancing its mission to enhance healthcare through...
Continue Reading
Incannex Healthcare's Remarkable Financial Progress Incannex Healthcare Inc. (NASDAQ: IXHL) is making impressive strides in the biopharmaceutical world, focusing on breakthrough treatments for chronic diseases. Their recent fiscal year report outlines not only financial outcomes but also a plethora of operational and clinical advancements aimed at addressing significant...
Continue Reading
Alpha Liquid Terminal Introduces ChatAnalyst Financial Agent Recently, a game-changing tool was launched that promises to redefine how individuals manage and interpret financial data. This is powered by the innovative company, Alpha Liquid Terminal. The newly unveiled AI-driven financial analyst agent, known as ChatAnalyst, is designed to simplify and streamline financial...
Continue Reading